Intracardiac Echocardiography Market - Forecast(2025 - 2031)
Intracardiac Echocardiography Market Overview:
The Intracardiac Echocardiography Market size is estimated to reach $997 Million by 2031, growing at a CAGR of 10.2% during the forecast period 2025-2031. The Intracardiac Echocardiography (ICE) Market is primarily driven by the increasing demand for minimally invasive diagnostic procedures, advancements in imaging technologies, and the growing prevalence of cardiovascular diseases. As the need for precise, real-time imaging during catheter-based procedures rises, ICE provides clinicians with high-resolution, detailed heart images, ensuring better decision-making during complex interventions.
A growing trend in the ICE market is the rise of portable and advanced ultrasound systems. A prime example of this is the collaboration between Mayo Clinic and UltraSight in June 2024, using AI to enhance point-of-care ultrasound (PoCUS) for cardiac care. Their goal is to develop algorithms that will guide users through the process of image acquisition and interpretation, addressing barriers to the broader adoption of PoCUS. Additionally, the use of AI continues to grow in the ICE market, innovative collaborations are emerging to enhance the precision and efficiency of cardiac care. In September 2024, iCardio.ai announced a partnership with Abbott to develop AI applications for the company’s imaging devices used in the treatment of cardiac arrhythmias. iCardio.ai will assist Abbott in automating model creation on the EnSite X cardiac mapping system, utilizing 2D intracardiac echo images captured by Abbott’s ICE catheters.
Market Snapshot:
Intracardiac Echocardiography Market - Report Coverage:
The “Intracardiac Echocardiography Market Report - Forecast (2025-2031)” by IndustryARC, covers an in-depth analysis of the following segments in the Intracardiac Echocardiography Market.
Attribute | Segment |
---|---|
By Product Type
|
|
By Application
|
|
By End-User
|
|
By Geography |
|
Key Takeaways:
• North America Leads the Market
North America held the largest share in the Intracardiac Echocardiography (ICE) market in 2024. With the rising prevalence of heart diseases in North America, particularly driven by key risk factors like high blood pressure and obesity, the demand for advanced diagnostic tools like intracardiac echocardiography is on the rise. According to the American Heart Association's presidential advisories published in June 2024 in the AHA journal Circulation, the projected rise in heart disease and stroke, along with key risk factors like high blood pressure and obesity, is expected to triple related healthcare costs to $1.8 trillion by 2050. Additionally, 6 in 10 adults in an older and more diverse U.S. population could be affected by cardiovascular diseases within the next 30 years. This growing prevalence of heart-related conditions in the region is driving the demand for advanced diagnostic tools like intracardiac echocardiography, further solidifying North America's leading position in the market.
• Intracardiac Echocardiography Systems is the Largest Segment
The Intracardiac Echocardiography Systems segment continues to lead the market due to its increasing adoption and advancements in technology. Notably, FUJIFILM Healthcare Americas Corporation announced the launch of its first-of-its-kind OPIE Transducer for on-pump intracardiac echocardiography (OPIE) aimed at improving septal myectomy procedures in April 2024. This innovation highlights the growing demand for specialized echocardiography systems. Additionally, in August 2024, Siemens Healthineers received FDA clearance for the ACUSON Origin, a dedicated cardiovascular ultrasound system powered by artificial intelligence (AI). These AI-driven features are designed to enhance cardiac procedures, particularly in diagnostics, structural heart disease, and electrophysiology, further boosting the Intracardiac Echocardiography Systems segment's dominance in the market.
• Electrophysiology as application is the Largest Segment
The Electrophysiology segment is the largest application in the intracardiac echocardiography market, owing to the rapid scientific and predictive analytics for diagnosing conditions like new-onset atrial fibrillation, ventricular tachycardia, and heart failure in cardiac electrophysiology over recent decades. Electrophysiology plays a critical role in diagnosing and treating various arrhythmias and heart rhythm disorders. As per a June 2024 article from Medical Xpress, researchers from the Massachusetts Institute of Technology (MIT) and Harvard Medical School have developed an ingestible device that can record electrophysiological signals from the gastrointestinal tract. This device could enhance the understanding and management of gastrointestinal disorders, highlighting the ongoing innovation in the field of electrophysiology and its potential expansion in medical applications beyond cardiology.
• Increasing Incidence of Cardiovascular Diseases Drives the Market
The increasing incidence of cardiovascular diseases (CVDs) is a key driver for the growth of the intracardiac echocardiography market. According to a May 2023 article by the World Heart Federation, deaths from cardiovascular diseases have surged by approximately 60% globally over the past three decades. CVD remains the leading cause of death worldwide, claiming nearly 20 million lives annually, as highlighted by the American Heart Association's Heart Disease and Stroke Statistics 2024 Update. Modifiable risk factors, such as obesity, particularly abdominal obesity are significant contributors to the rising prevalence of cardiovascular conditions, further escalating the demand for advanced diagnostic technologies like intracardiac echocardiography.
Key Market Players:
Product/Service launches, approvals, patents and events, acquisitions, partnerships, and collaborations are key strategies adopted by players in the Intracardiac Echocardiography Market. The top 10 companies in this industry are listed below:
1) Abbott Laboratories
2) Medtronic plc
3) Boston Scientific Corporation
4) Koninklijke Philips N.V.
5) Siemens Healthineers
6) GE Healthcare
7) Johnson & Johnson
8) Stryker Corporation
9) Conavi Medical Corp.
10) FUJIFILM
Scope of the Report:
Report Metric | Details |
---|---|
Base Year Considered |
2024 |
Forecast Period |
2025–2031 |
CAGR |
10.2% |
Market Size in 2031 |
$997 Million |
Segments Covered |
By Product Type, By Application, By End-User and By Geography. |
Geographies Covered |
North America (U.S., Canada and Mexico), Europe (Germany, France, UK, Italy, , Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America), Rest of the World (Middle East and Africa). |
Key Market Players |
|
For more Lifesciences and Healthcare Market reports, please click here
The Intracardiac Echocardiography Market is forecast to grow at 6% during the forecast period 2023-2030.
The Global Intracardiac Echocardiography Market size is estimated to be $ 0.5 Billion in 2022 and is projected to reach $ 0.6 Billion by 2030.
The leading players in the Intracardiac Echocardiography Market are Boston Scientific, Johnson & Johnson, Philips Healthcare, GE Healthcare, etc. and others.